Immunocore Holdings plc (IMCR) Earnings History
Net Loss13 years of earnings data (2013–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Immunocore Holdings plc (IMCR) Earnings Overview
As of June 22, 2026, Immunocore Holdings plc (IMCR) reported trailing twelve-month net income of -$19M, reflecting +48.0% year-over-year growth. The company earned $-0.36 per diluted share over the past four quarters, with a net profit margin of -8.9%.
Looking at the long-term picture, IMCR's historical earnings data spans multiple years. The company achieved its highest annual net income of $20M in fiscal 2015.
Immunocore Holdings plc is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including KYMR (-$315M net income, -794.4% margin), RCUS (-$369M net income, -142.9% margin), AGEN ($65M net income, 0.1% margin), IMCR has outperformed on profitability metrics. Compare IMCR vs KYMR →
IMCR Earnings vs Peers
Earnings metrics vs comparable public companies
IMCR Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$26M | +35.3% | -$34M | $-0.53 | -8.9% | -11.3% |
| 2024 | -$41M | +6.7% | -$56M | $-1.02 | -16.5% | -22.7% |
| 2023 | -$44M | -0.7% | -$47M | $-0.89 | -22.2% | -23.9% |
| 2022 | -$43M | +67.4% | -$43M | $-0.95 | -30.1% | -29.7% |
| 2021 | -$133M | -80.1% | -$129M | $-3.00 | -493.4% | -478.5% |
| 2020 | -$74M | +28.7% | -$86M | $-2.33 | -246.0% | -286.2% |
| 2019 | -$104M | -45.1% | -$118M | $-3.81 | -404.9% | -460.9% |
| 2018 | -$72M | -8.9% | -$93M | $-2.62 | -302.8% | -395.1% |
| 2017 | -$66M | -131.5% | -$91M | $-26.74 | -343.1% | -473.7% |
| 2016 | -$28M | -242.9% | -$40M | $-11.60 | -140.5% | -197.3% |
| 2015 | $20M | +320.3% | -$20M | $0.00 | 117.4% | -119.2% |
| 2014 | -$9M | -51.3% | -$12M | $-4.08 | -87.7% | -114.6% |
| 2013 | -$6M | - | -$8M | $0.00 | -180.6% | -234.3% |
Download Data
Export IMCR earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
13+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
IMCR — Frequently Asked Questions
Quick answers to the most common questions about buying IMCR stock.
What is IMCR earnings per share (EPS)?
IMCR trailing twelve-month (TTM) diluted EPS is $-0.36, reflecting +48.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2013 to 2025 is available in the table on this page.
What is Immunocore Holdings plc's net income?
Immunocore Holdings plc (IMCR) trailing twelve-month net income is $-19M as of 2025. Earnings grew +48.0% year-over-year.
Is IMCR profitable?
IMCR is not currently profitable on a TTM basis, reporting a net loss of $-19M. Net margin is -8.9%. Investors should monitor for a return to profitability.
What is IMCR's earnings growth rate?
IMCR compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2013 to 2025.
What are IMCR's profit margins?
Immunocore Holdings plc net profit margin is -8.9%, operating margin is -11.3%, and gross margin is +97.9%. Below-average margins reflect competitive or cost pressures. Return on Equity is -7.1%.
Is IMCR growing earnings?
Yes, IMCR earnings are accelerating — EPS growth of +48.0% exceeds the 5-year CAGR of N/A. TTM net income reached $-19M. Earnings momentum is strengthening.
What was IMCR's best earnings year?
Immunocore Holdings plc's highest annual net income on record is $20M, achieved in fiscal year 2015. Earnings history on this page spans 2013 to 2025 and includes all annual and quarterly figures.
What were IMCR's earnings last quarter?
IMCR's most recent reported quarter was Q1 2026. Net income was $13M with diluted EPS of $0.25. For a full breakdown of all quarters, see the quarterly earnings table on this page.